Home Tags HIV
HIV Related Content
Experts Dr Michel Gasana & Dr Frank Lule from World Health Organization – Regional Office for Africa, provide an update on the global picture of Tuberculosis.
There are important differences in the symptoms of monkeypox between the current outbreak and previous outbreaks in endemic regions.
Scientists at AIDS 2022 describe how new technological insights into HIV latent cells could help HIV cure research.
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
The WHO have new treatment guidelines for cryptococcal meningitis in people living with HIV - a single high dose of liposomal amphotericin B.
The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.
Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.
The stigma, discrimination and lack of understanding around HIV is still persisting even 41 years after the first reported case
Research published in BMJ Global Health has found a hotspot for HIV, tuberculosis and malaria in a regional corner of Africa.
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
Acknowledging pleasure as a key driver of sexual behaviour has more success in teaching safe sex than traditional sex education – as well as targeting STI/HIV risk reduction.
Dr Michel Gasana & Dr Hugues Lago from WHO - Regional Office for Africa, spoke to OAG about the status of tuberculosis prevention
A survey, conducted over 20 years in 35 African countries, suggests that one in ten sexually active men are 50% more likely to be living with HIV.
December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.
Dr Glass, Director of the Fogarty International Center, and Director at the NIH, explores the relationship between NIH and the health research community
Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
A new study focuses on HIV data in sub-Saharan Africa, analysing the number of people living with HIV in 47 countries, the population distribution, and the locations of healthcare facilities.